Volitionrx Ltd
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleos… Read more
Volitionrx Ltd (VNRX) - Total Assets
Latest total assets as of September 2025: $6.45 Million USD
Based on the latest financial reports, Volitionrx Ltd (VNRX) holds total assets worth $6.45 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Volitionrx Ltd - Total Assets Trend (2004–2024)
This chart illustrates how Volitionrx Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Volitionrx Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Volitionrx Ltd's total assets of $6.45 Million consist of 43.2% current assets and 56.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 34.7% |
| Accounts Receivable | $110.57K | 1.2% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $313.75K | 3.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2004–2024)
This chart illustrates how Volitionrx Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Volitionrx Ltd's current assets represent 43.2% of total assets in 2024, a decrease from 100.0% in 2004.
- Cash Position: Cash and equivalents constituted 34.7% of total assets in 2024, down from 100.0% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2004.
- Asset Diversification: The largest asset category is intangible assets at 3.3% of total assets.
Volitionrx Ltd Competitors by Total Assets
Key competitors of Volitionrx Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Volitionrx Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Volitionrx Ltd generates 0.13x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Volitionrx Ltd is currently not profitable relative to its asset base.
Volitionrx Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.12 | 0.22 | 3.26 |
| Quick Ratio | 0.12 | 0.22 | 3.21 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-10.09 Million | $ -23.48 Million | $ 14.10 Million |
Volitionrx Ltd - Advanced Valuation Insights
This section examines the relationship between Volitionrx Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 38.44 |
| Latest Market Cap to Assets Ratio | 1.89 |
| Asset Growth Rate (YoY) | -66.4% |
| Total Assets | $9.40 Million |
| Market Capitalization | $17.77 Million USD |
Valuation Analysis
Above Book Valuation: The market values Volitionrx Ltd's assets above their book value (1.89 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Volitionrx Ltd's assets decreased by 66.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Volitionrx Ltd (2004–2024)
The table below shows the annual total assets of Volitionrx Ltd from 2004 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $9.40 Million | -66.37% |
| 2023-12-31 | $27.95 Million | +52.78% |
| 2022-12-31 | $18.30 Million | -33.45% |
| 2021-12-31 | $27.49 Million | +5.12% |
| 2020-12-31 | $26.15 Million | +22.82% |
| 2019-12-31 | $21.29 Million | +21.74% |
| 2018-12-31 | $17.49 Million | +19.59% |
| 2017-12-31 | $14.62 Million | -40.87% |
| 2016-12-31 | $24.73 Million | +220.71% |
| 2015-12-31 | $7.71 Million | +124.64% |
| 2014-12-31 | $3.43 Million | +65.79% |
| 2013-12-31 | $2.07 Million | -6.59% |
| 2012-12-31 | $2.22 Million | -1.27% |
| 2011-12-31 | $2.25 Million | +462838.97% |
| 2010-12-31 | $485.00 | -85.91% |
| 2009-12-31 | $3.44K | +3.71% |
| 2008-12-31 | $3.32K | -23.51% |
| 2007-12-31 | $4.34K | +92.20% |
| 2006-12-31 | $2.26K | +2091.26% |
| 2005-12-31 | $103.00 | +51.47% |
| 2004-12-31 | $68.00 | -- |